Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Hundmejean MartinaDirector | Option exercise | M | — 495 sh | May 18, 2026 |
| 8 | Newcomb Matthew SChief Financial Officer | Gift | G | — 17.7K sh | May 18, 2026 traded May 18, 2026 |
| 8 | Spetzler David BaxleyPresident | Tax withholding | F | $211K 13.9K sh | May 18, 2026 traded May 15, 2026 |
| 8 | Newcomb Matthew SChief Financial Officer | Gift | G | — 17.7K sh | May 18, 2026 traded May 18, 2026 |
| 8 | Kazmi Amir A.SVP - Chief Technology Officer | Tax withholding | F | $100K 1,692 sh | May 18, 2026 traded May 15, 2026 |
| 8 | Esaka FumihideDirector, Chief Executive Officer | Option exercise | M | $183K 14.5K sh | May 18, 2026 traded May 15, 2026 |
| 8 | Britt Christopher RDirector, Chief Executive Officer | Tax withholding | F | $164K 9,170 sh | May 18, 2026 traded May 15, 2026 |
| 8 | Denton John RusselSee Remarks | Tax withholding | F | $92K 6,047 sh | May 18, 2026 traded May 15, 2026 |
| 8 | Hanson Scott McLeanDirector, Chief Technology Officer | Option exercise | M | $66K 8,100 sh | May 18, 2026 traded May 15, 2026 |
| 5 | Huang Michael F.Sr. VP of Clinical Development | Disposition to issuer | D | — 110.0K sh | May 18, 2026 traded May 18, 2026 |
| 5 | Huang Michael F.Sr. VP of Clinical Development | Disposition to issuer | D | — 13.8K sh | May 18, 2026 traded May 18, 2026 |
| 5 | Esaka FumihideDirector, Chief Executive Officer | Option exercise | M | — 6,601 sh | May 18, 2026 traded May 15, 2026 |
| 5 | Huang Michael F.Sr. VP of Clinical Development | Disposition to issuer | D | — 11.9K sh | May 18, 2026 traded May 18, 2026 |
| 5 | Sever MichalCMO | Option exercise | M | — 3,437 sh | May 18, 2026 traded May 15, 2026 |
| 5 | Sever MichalCMO | Option exercise | M | — 1,563 sh | May 18, 2026 traded May 15, 2026 |
| 5 | Huang Michael F.Sr. VP of Clinical Development | Disposition to issuer | D | — 39.8K sh | May 18, 2026 traded May 18, 2026 |
| 4 | Allison JonathanChief Administrative Officer | Open-market sale · 10b5-1 plan | SELL | $90K 1,606 sh | May 18, 2026 traded May 15, 2026 |
| 2 | Mazzara PhilipGeneral Counsel and Secretary | Grant or award | A | $16K 131 sh | May 18, 2026 traded May 14, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | — 15.0K sh | May 18, 2026 traded May 14, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | $156K 15.0K sh | May 18, 2026 traded May 14, 2026 |
| 66 | Musser ForySenior VP, Development | Open-market sale | SELL | $26.17M 2.00M sh | May 15, 2026 traded May 14, 2026 |
| 58 | Parekh Salil S.Director, CEO & Managing Director | Open-market sale | SELL | $112.84M 95.8K sh | May 15, 2026 traded May 8, 2026 |
| 51 | Warburg Pincus & Co.Director, 10% Owner | Open-market sale | SELL | $289.75M 19.10M sh | May 15, 2026 traded May 13, 2026 |
| 51 | Warburg Pincus & Co.Director, 10% Owner | Open-market sale | SELL | $289.75M 19.10M sh | May 15, 2026 traded May 13, 2026 |
| 50 | Sutton ToddVP Corporate Controller | Open-market sale | SELL | $422K 2,574 sh | May 15, 2026 traded May 14, 2026 |
| 48 | Coppetti Caspar FelixDirector, Executive Officer & Co-CEO | Open-market purchase | BUY | $1.87M 50.9K sh | May 15, 2026 traded May 14, 2026 |
| 48 | Bernhard OlivierDirector, Executive Officer | Open-market purchase | BUY | $1.87M 50.9K sh | May 15, 2026 traded May 14, 2026 |
| 48 | Allemann David MichaelDirector, Executive Officer & Co-CEO | Open-market purchase | BUY | $1.87M 50.9K sh | May 15, 2026 traded May 14, 2026 |
| 47 | Larson Keith DGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $7.80M 555.6K sh | May 15, 2026 traded May 15, 2026 |
| 47 | Larson Keith DGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $7.26M 555.6K sh | May 15, 2026 traded May 14, 2026 |
| 45 | Bernhard OlivierDirector, Executive Officer | Open-market purchase | BUY | $329K 9,144 sh | May 15, 2026 traded May 14, 2026 |
| 45 | Sinha AnkurChief Product and Tech Officer | Open-market sale | SELL | $1.17M 50.0K sh | May 15, 2026 traded May 14, 2026 |
| 45 | Allemann David MichaelDirector, Executive Officer & Co-CEO | Open-market purchase | BUY | $329K 9,144 sh | May 15, 2026 traded May 14, 2026 |
| 45 | Coppetti Caspar FelixDirector, Executive Officer & Co-CEO | Open-market purchase | BUY | $329K 9,147 sh | May 15, 2026 traded May 14, 2026 |
| 43 | Emery JeffreyPresident - Global Fire Safety | Open-market sale | SELL | $1.79M 53.5K sh | May 15, 2026 traded May 13, 2026 |
| 43 | Sable KyleChief Financial Officer | Open-market sale | SELL | $1.53M 46.3K sh | May 15, 2026 traded May 13, 2026 |
| 42 | Mitchell William ClydePresident of AFC | Open-market sale | SELL | $234K 6,500 sh | May 15, 2026 traded May 14, 2026 |
| 41 | Larsen Larry CExecutive Vice President & COO | Open-market sale | SELL | $918K 12.0K sh | May 15, 2026 traded May 14, 2026 |
| 39 | Blumenstock Gerald MEVP, Research, Dev. & Eng. | Open-market sale | SELL | $165K 1,015 sh | May 15, 2026 traded May 14, 2026 |
| 39 | Ndlovu JulyDirector | Open-market purchase | BUY | $372K 15.0K sh | May 15, 2026 traded May 13, 2026 |